CONMED Corp — Director's Dealing 2020

Oct 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-10-30

Reporting Person: SHAGORY PETER K (EVP, STRAT & CORP DEVT)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-30	Options To Purchase Common Stock	$97.69	J	8050	Disposed	2030-03-02	Common Stock (8050)	Direct
2020-10-30	Options To Purchase Common Stock	$78.76	J	9840	Disposed	2029-03-01	Common Stock (9840)	Direct
2020-10-30	Options To Purchase Common Stock	$41.93	J	8865	Disposed	2027-03-01	Common Stock (8865)	Direct
2020-10-30	Options To Purchase Common Stock	$59.96	J	11960	Disposed	2028-03-01	Common Stock (11960)	Direct
2020-10-30	Options To Purchase Common Stock	$39.87	J	1998	Disposed	2026-03-01	Common Stock (1998)	Direct
2020-10-30	Sars (Stock Appreciation Rights)	$55.42	J	11000	Disposed	2025-05-11	Common Stock (11000)	Direct

Footnotes

F1: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee.

F2: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period

F4: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F5: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.